Comments
Loading...
Larimar Therapeutics (LRMR) Forecast
NewsEarningsLarimar Therapeutics (LRMR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLarimar Therapeutics (NASDAQ:LRMR) Stock Quotes, Forecast and News Summary
Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Larimar Therapeutics (LRMR) stock?
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Who are Larimar Therapeutics (LRMR) competitors?
Other companies in Larimar Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?
Larimar Therapeutics has a consensus price target of $19.00.
What is the current price for Larimar Therapeutics (LRMR)?
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $7.76 last updated November 14, 2024 at 3:01 PM EST.
Does Larimar Therapeutics (LRMR) pay a dividend?
There are no upcoming dividends for Larimar Therapeutics.
When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?
Larimar Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is Larimar Therapeutics (LRMR) going to split?
There is no upcoming split for Larimar Therapeutics.
What sector and industry does Larimar Therapeutics (LRMR) operate in?
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.